Krystal Biotech, Inc. (KRYS) Operating margin 2023–2025
Krystal Biotech, Inc. (KRYS) operating margin by fiscal year — reported operating income divided by reported revenue.
41.5%FY2025 · since FY2023: -216.2% → 41.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 41.5% | +18.8 pp |
| FY2024 | 22.6% | +238.8 pp |
| FY2023 | -216.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More KRYS financial trends
KRYS RevenueKRYS Net incomeKRYS Net marginKRYS Gross profitKRYS Gross marginKRYS Operating incomeKRYS Operating cash flowKRYS Free cash flowKRYS Capital expendituresKRYS Return on equityKRYS Stock buybacksKRYS Dividends paidKRYS Total assetsKRYS Total liabilitiesKRYS Shareholders’ equityKRYS overview →